Prevention and management of endocarditis after transcatheter pulmonary valve replacement: current status and future prospects

References

• Tutarel O, Alonso-Gonzalez R, Montanaro C, et al. Infective endocarditis in adults with congenital heart disease remains a lethal disease. Heart. 2018;104:161–165.
   PubMed Web of Science ®Google Scholar
• Kuijpers JM, Koolbergen DR, Groenink M, et al. Incidence, risk factors, and predictors of infective endocarditis in adult congenital heart disease: focus on the use of prosthetic material. Eur Heart J. 2017;38:2048–2056.
   PubMed Web of Science ®Google Scholar
• Weber R, Berger C, Balmer C, et al. Interventions using foreign material to treat congenital heart disease in children increase the risk for infective endocarditis. Pediatr Infect Dis J. 2008;27:544–550.
   PubMed Web of Science ®Google Scholar
• Cahill TJ, Jewell PD, Denne L, et al. Contemporary epidemiology of infective endocarditis in patients with congenital heart disease: A UK prospective study. Am Heart J. 2019;215:70–77.
   PubMed Web of Science ®Google Scholar
• Kempny A, Dimopoulos K, Uebing A, et al. Outcome of cardiac surgery in patients with congenital heart disease in England between 1997 and 2015. PLoS One. 2017;12(6):e0178963.
   PubMed Web of Science ®Google Scholar
• Rushani D, Kaufman JS, Ionescu-Ittu R, et al. Infective endocarditis in children with congenital heart disease: cumulative incidence and predictors. Circulation. 2013;128:1412–1419.
   PubMed Web of Science ®Google Scholar
• Knirsch W, Nadal D. Infective endocarditis in congenital heart disease. Eur J Pediatr. 2011;170:1111–1127.
   PubMed Web of Science ®Google Scholar
• Shahanavaz S, McElhinney DB. Transcatheter pulmonary valve replacement: evolving indications and application. Future Cardiol. 2018;14:511‐24.
   PubMed Web of Science ®Google Scholar
• Bonhoeffer P, Boudjemline Y, Saliba Z, et al. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet. 2000;356:1403–1405.
   PubMed Web of Science ®Google Scholar
• Khambadkone S, Coats L, Taylor A, et al. Percutaneous pulmonary valve implantation in humans: results in 59 consecutive patients. Circulation. 2005;112:1189–1197.
   PubMed Web of Science ®Google Scholar
• Edwards SAPIEN XT transcatheter heart valve with the NovaFlex+ delivery system: instructions for use – pulmonic. [cited 2020 Oct 2]. Available from: http://www.accessdata.fda.gov/cdrh_docs/pdf13/P130009S037d.pdf
   Google Scholar
• Lurz P, Coats L, Khambadkone S, et al. Percutaneous pulmonary valve implantation: impact of evolving technology and learning curve on clinical outcome. Circulation. 2008;117:1964–1972.
   PubMed Web of Science ®Google Scholar
• Eicken A, Ewert P, Hager A, et al. Percutaneous pulmonary valve implantation: two-centre experience with more than 100 patients. Eur Heart J. 2011;32:1260–1265.
   PubMed Web of Science ®Google Scholar
• Gillespie MJ, Rome JJ, Levi DS, et al. Melody valve implant within failed bioprosthetic valves in the pulmonary position: a multicenter experience. Circ Cardiovasc Interv. 2012;5:862–870.
   PubMed Web of Science ®Google Scholar
• Biernacka EK, Rużyłło W, Demkow M, et al. Transcatheter pulmonary valve implantation in patients with right ventricular outflow tract dysfunction: early and mid-term results. J Invasive Cardiol. 2015;27:E82–9.
   PubMed Web of Science ®Google Scholar
• Butera G, Milanesi O, Spadoni I, et al. Melody transcatheter pulmonary valve implantation. results from the registry of the Italian Society of Pediatric Cardiology (SICP). Catheter Cardiovasc Interv. 2013;81:310–316.
   PubMed Web of Science ®Google Scholar
• Borik S, Crean A, Horlick E, et al. Percutaneous pulmonary valve implantation: 5 years of follow-up: does age influence outcomes? Circ Cardiovasc Interv. 2015;8:e001745.
   PubMed Web of Science ®Google Scholar
• Armstrong AK, Balzer DT, Cabalka AK, et al. One-year follow-up of the Melody transcatheter pulmonary valve multicenter post-approval study. JACC Cardiovasc Interv. 2014;7:1254–1262.
   PubMed Web of Science ®Google Scholar
• Kenny D, Rhodes JF, Fleming GA, et al. 3-year outcomes of the Edwards SAPIEN transcatheter heart valve for conduit failure in the pulmonary position from the COMPASSION multicenter clinical trial. JACC Cardiovasc Interv. 2018;11:1920–1929.
   PubMed Web of Science ®Google Scholar
• Lurz P, Nordmeyer J, Giardini A, et al. Early versus late functional outcome after successful percutaneous pulmonary valve implantation: are the acute effects of altered right ventricular loading all we can expect? J Am Coll Cardiol. 2011;57:724–731.
   PubMed Web of Science ®Google Scholar
• Gillespie MJ, McElhinney DB, Kreutzer J, et al. Transcatheter pulmonary valve replacement for right ventricular outflow tract conduit dysfunction after the ross procedure. Ann Thorac Surg. 2015;100:996–1002.
   PubMed Web of Science ®Google Scholar
• Cheatham JP, Hellenbrand WE, Zahn EM, et al. Clinical and hemodynamic outcomes up to 7 years after transcatheter pulmonary valve replacement in the US melody valve investigational device exemption trial. Circulation. 2015;131:1960–1970.
   PubMed Web of Science ®Google Scholar
• Lehner A, Dashkalova T, Ulrich S, et al. Intermediate outcomes of transcatheter pulmonary valve replacement with the Edwards Sapien 3 valve - German experience. Expert Rev Med Devices. 2019;16:829–834.
   PubMed Web of Science ®Google Scholar
• Tanase D, Ewert P, Georgiev S, et al. Tricuspid regurgitation does not impact right ventricular remodeling after percutaneous pulmonary valve implantation. JACC Cardiovasc Interv. 2017;10:701–708.
   PubMed Web of Science ®Google Scholar
• Jones TK, Rome JJ, Armstrong AK, et al. Transcatheter pulmonary valve replacement reduces tricuspid regurgitation in patients with right ventricular volume/pressure overload. J Am Coll Cardiol. 2016;68:1525–1535.
   PubMed Web of Science ®Google Scholar
• Fraisse A, Aldebert P, Malekzadeh-Milani S, et al. Melody ® transcatheter pulmonary valve implantation: results from a French registry. Arch Cardiovasc Dis. 2014;107:607–614.
   PubMed Web of Science ®Google Scholar
• Nordmeyer J, Ewert P, Gewillig M, et al. Acute and midterm outcomes of the post-approval MELODY Registry: a multicentre registry of transcatheter pulmonary valve implantation. Eur Heart J. 2019;40:2255–2264.
   PubMedGoogle Scholar
• Cabalka AK, Hellenbrand WE, Eicken A, et al. Relationships among conduit type, pre-stenting, and outcomes in patients undergoing transcatheter pulmonary valve replacement in the prospective North American and European melody valve trials. JACC Cardiovasc Interv. 2017;10:1746–1759.
   PubMedGoogle Scholar
• Martin MH, Meadows J, McElhinney DB, et al. Safety and feasibility of melody transcatheter pulmonary valve replacement in the native right ventricular outflow tract: a multicenter pediatric heart network scholar study. JACC Cardiovasc Interv. 2018;11:1642–1650.
   PubMed Web of Science ®Google Scholar
• Sinha S, Aboulhosn J, Asnes J, et al. Initial results from the off-label use of the SAPIEN S3 valve for percutaneous transcatheter pulmonary valve replacement: A multi-institutional experience. Catheter Cardiovasc Interv. 2019;93:455–463.
   PubMed Web of Science ®Google Scholar
• Shahanavaz S, Qureshi AM, Levi DS, et al. Transcatheter pulmonary valve replacement with the melody valve in small diameter expandable right ventricular outflow tract conduits. JACC Cardiovasc Interv. 2018;11:554–564.
   PubMed Web of Science ®Google Scholar
• Buber J, Bergersen L, Lock JE, et al. Bloodstream infections occurring in patients with percutaneously implanted bioprosthetic pulmonary valve: a single-center experience. Circ Cardiovasc Interv. 2013;6:301–310.
   PubMed Web of Science ®Google Scholar
• Tanase D, Ewert P, Hager A, et al. Infective endocarditis after percutaneous pulmonary valve implantation - A long-term single centre experience. Int J Cardiol. 2018;265:47–51.
   PubMed Web of Science ®Google Scholar
• McElhinney DB, Benson LN, Eicken A, et al. Infective endocarditis after transcatheter pulmonary valve replacement using the Melody valve: combined results of 3 prospective North American and European studies. Circ Cardiovasc Interv. 2013;6:292–300.
   PubMed Web of Science ®Google Scholar
• McElhinney DB, Sondergaard L, Armstrong AK, et al. Endocarditis after transcatheter pulmonary valve replacement. J Am Coll Cardiol. 2018;72:2717–2728.
   PubMed Web of Science ®Google Scholar
• Van Dijck I, Budts W, Cools B, et al. Infective endocarditis of a transcatheter pulmonary valve in comparison with surgical implants. Heart. 2015;101:788–793.
   PubMed Web of Science ®Google Scholar
• O’Donnell C, Holloway R, Tilton E, et al. Infective endocarditis following Melody valve implantation: comparison with a surgical cohort. Cardiol Young. 2017;27:294–301.
   PubMed Web of Science ®Google Scholar
• Alsoufi B, Al-Joufan M, Al-Omrani A, et al. Obstruction of a percutaneous pulmonary valve by an Aspergillus mycotic thrombus mimicking massive pulmonary embolus. Ann Thorac Surg. 2012;94:e5–6.
   PubMed Web of Science ®Google Scholar
• Atamanyuk I, Raja SG, Kostolny M. Bartonella henselae endocarditis of percutaneously implanted pulmonary valve: a case report. J Heart Valve Dis. 2011;20:94–97.
   PubMed Web of Science ®Google Scholar
• Chaudhry-Waterman N, Bergersen L, Buber J. Bacterial endocarditis manifesting as outflow tract obstruction in two patients implanted with percutaneous prosthetic pulmonary valves. Can J Cardiol. 2015;31:1204.e1–3.
   PubMed Web of Science ®Google Scholar
• Georgievskaya Z, Nowalk AJ, Randhawa P, et al. Bartonella henselae endocarditis and glomerulonephritis with dominant C3 deposition in a 21-year-old male with a Melody transcatheter pulmonary valve: case report and review of the literature. Pediatr Dev Pathol 2014;17:312–320.
   Google Scholar
• Johnson JN, Miller SG, Lodge AJ. Corynebacterium endocarditis of a percutaneously placed transcatheter pulmonary valve. Cardiol Young. 2014;24:932–934.
   PubMed Web of Science ®Google Scholar
• Patel M, Iserin L, Bonnet D, et al. Atypical malignant late infective endocarditis of Melody valve. J Thorac Cardiovasc Surg. 2012;143:e32–5.
   PubMed Web of Science ®Google Scholar
• Malekzadeh-Milani S, Ladouceur M, Patel M, et al. Incidence and predictors of Melody® valve endocarditis: a prospective study. Arch Cardiovasc Dis. 2015;108:97–106.
   PubMed Web of Science ®Google Scholar
• Hascoet S, Mauri L, Claude C, et al. Infective endocarditis risk after percutaneous pulmonary valve implantation with the Melody and Sapien valves. JACC Cardiovasc Interv. 2017;10:510–517.
   PubMed Web of Science ®Google Scholar
• Malekzadeh-Milani S, Houeijeh A, Jalal Z, et al. French working group of cardiac catheterization in congenital heart disease patients. French national survey on infective endocarditis and the Melody™ valve in percutaneous pulmonary valve implantation. Arch Cardiovasc Dis. 2018;111:497–506.
   PubMed Web of Science ®Google Scholar
• Villafañe J, Baker GH, Austin EH 3rd, et al. Melody pulmonary valve bacterial endocarditis: experience in four pediatric patients and a review of the literature. Catheter Cardiovasc Interv. 2014;84:212–218.
   PubMed Web of Science ®Google Scholar
• Sadeghi S, Wadia S, Lluri G, et al. Risk factors for infective endocarditis following transcatheter pulmonary valve replacement in patients with congenital heart disease. Catheter Cardiovasc Interv. 2019;94:625–635.
   PubMed Web of Science ®Google Scholar
• Patel M, Malekzadeh-Milani S, Ladouceur M, et al. Percutaneous pulmonary valve endocarditis: incidence, prevention and management. Arch Cardiovasc Dis. 2014;107:615–624.
   PubMed Web of Science ®Google Scholar
• Uebing A, Rigby ML. The problem of infective endocarditis after transcatheter pulmonary valve implantation. Heart. 2015;101:749–751.
   PubMed Web of Science ®Google Scholar
• Amat-Santos IJ, Ribeiro HB, Urena M, et al. Prosthetic valve endocarditis after transcatheter valve replacement: a systematic review. JACC Cardiovasc Interv. 2015;8:334–346.
   PubMed Web of Science ®Google Scholar
• Vollroth M, Daehnert I, Kostelka M, et al. First case of blood-culture proven Staphylococcus aureus endocarditis of a Sapien® XT valve after percutaneous pulmonary valve implantation. Eur J Cardiothorac Surg. 2015;48:e124–5.
   PubMed Web of Science ®Google Scholar
• Cheung G, Vejlstrup N, Ihlemann N, et al. Infective endocarditis following percutaneous pulmonary valve replacement: diagnostic challenges and application of intra-cardiac echocardiography. Int J Cardiol. 2013;169:425–429.
   PubMed Web of Science ®Google Scholar
• Gröning M, Tahri NB, Søndergaard L, et al. Infective endocarditis in right ventricular outflow tract conduits: a register-based comparison of homografts, Contegra grafts and Melody transcatheter valves. Eur J Cardiothorac Surg. 2019;56:87–93.
   PubMed Web of Science ®Google Scholar
• Lluri G, Levi DS, Miller E, et al. Incidence and outcome of infective endocarditis following percutaneous versus surgical pulmonary valve replacement. Catheter Cardiovasc Interv. 2018;91:277–284.
   PubMed Web of Science ®Google Scholar
• Haas NA, Bach S, Vcasna R, et al. The risk of bacterial endocarditis after percutaneous and surgical biological pulmonary valve implantation. Int J Cardiol. 2018;268:55–60.
   PubMed Web of Science ®Google Scholar
• Lehner A, Haas NA, Dietl M, et al. The risk of infective endocarditis following interventional pulmonary valve implantation: A meta-analysis. J Cardiol. 2019;74:197–205.
   PubMed Web of Science ®Google Scholar
• Sharma A, Cote AT, Hosking MCK, et al. A systematic review of infective endocarditis in patients with bovine jugular vein valves compared with other valve types. JACC Cardiovasc Interv. 2017;10:1449–1458.
   PubMed Web of Science ®Google Scholar
• Chatterjee A, Bajaj NS, McMahon WS, et al. Transcatheter pulmonary valve implantation: a comprehensive systematic review and meta-analyses of observational studies. J Am Heart Assoc. 2017;6:e006432.
   PubMed Web of Science ®Google Scholar
• McElhinney DB. Reflection and rationalization: making sense of the literature on endocarditis after transcatheter pulmonary valve replacement. Circ Cardiovasc Interv. 2017;10:e004983.
   PubMed Web of Science ®Google Scholar
• Østergaard L, Valeur N, Ihlemann N, et al. Incidence of infective endocarditis among patients considered at high risk. Eur Heart J. 2018;39:623–629.
   PubMed Web of Science ®Google Scholar
• Martin MH, Shahanavaz S, Peng LF, et al. Percutaneous transcatheter pulmonary valve replacement in children weighing less than 20 kg. Catheter Cardiovasc Interv. 2018;91:485–494.
   PubMed Web of Science ®Google Scholar
• Wilson W, Taubert KA, Gewitz M, et al. American heart association rheumatic fever, endocarditis, and Kawasaki Disease Committee; American heart association council on cardiovascular disease in the young; American heart association council on clinical cardiology; American heart association council on cardiovascular surgery and anesthesia; Quality of care and outcomes research interdisciplinary working group. Prevention of infective endocarditis: guidelines from the American heart association: a guideline from the American heart association rheumatic fever, endocarditis, and Kawasaki Disease Committee, council on cardiovascular disease in the young, and the council on clinical cardiology, council on cardiovascular surgery and anesthesia, and the quality of care and outcomes research interdisciplinary working group. Circulation. 2007;116:1736–1754.
   PubMed Web of Science ®Google Scholar
• Sullam PM, Bayer AS, Foss WM, et al. Diminished platelet binding in vitro by Staphylococcus aureus is associated with reduced virulence in a rabbit model of infective endocarditis. Infect Immun. 1996;64:4915–4921.
   PubMed Web of Science ®Google Scholar
• Veloso TR, Que YA, Chaouch A, et al. Prophylaxis of experimental endocarditis with antiplatelet and antithrombin agents: a role for long-term prevention of infective endocarditis in humans? J Infect Dis. 2015;211:72–79.
   PubMed Web of Science ®Google Scholar
• Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30:633–638.
   PubMed Web of Science ®Google Scholar
• Miranda WR, Connolly HM, Bonnichsen CR, et al. Prosthetic pulmonary valve and pulmonary conduit endocarditis: clinical, microbiological and echocardiographic features in adults. Eur Heart J Cardiovasc Imaging. 2016;17:936–943.
   PubMed Web of Science ®Google Scholar
• Awad SM, Masood SA, Gonzalez I, et al. The use of intracardiac echocardiography during percutaneous pulmonary valve replacement. Pediatr Cardiol. 2015;36:76–83.
   PubMed Web of Science ®Google Scholar
• Whiteside W, Pasquali SK, Yu S, et al. The utility of intracardiac echocardiography following Melody transcatheter pulmonary valve implantation. Pediatr Cardiol. 2015;36:1754–1760.
   PubMed Web of Science ®Google Scholar
• Yedidya I, Stein GY, Vaturi M, et al. Positron emission tomography/computed tomography for the diagnosis of endocarditis in patients with pulmonic stented valve/pulmonic stent. Ann Thorac Surg. 2011;91:287–289.
   PubMed Web of Science ®Google Scholar
• Saby L, Laas O, Habib G, et al. Positron emission tomography/computed tomography for diagnosis of prosthetic valve endocarditis: increased valvular 18F-fluorodeoxyglucose uptake as a novel major criterion. J Am Coll Cardiol. 2013;61:2374–2382.
   PubMed Web of Science ®Google Scholar
• Hussain ST, Shrestha NK, Witten J, et al. Rarity of invasiveness in right-sided infective endocarditis. J Thorac Cardiovasc Surg. 2018;155:54–61.
   PubMed Web of Science ®Google Scholar
• Shahanavaz S, Berger F, Jones TK, et al. Outcomes after transcatheter reintervention for dysfunction of a previously implanted transcatheter pulmonary valve. JACC Cardiovasc Interv. 2020;13:1529–1540.
   PubMed Web of Science ®Google Scholar
• Kiani S, Sabayon D, Lloyd MS, et al. Outcomes of percutaneous vacuum-assisted debulking of large vegetations as an adjunct to lead extraction. Pacing Clin Electrophysiol. 2019;42:1032–1037.
   PubMed Web of Science ®Google Scholar
• Georgiev S, Ewert P, Eicken A, et al. Munich comparative study: prospective long-term outcome of the transcatheter melody valve versus surgical pulmonary bioprosthesis with up to 12 years of follow-up. Circ Cardiovasc Interv. 2020 Jul;13(7):e008963. PMID: 32600110. .
   PubMed Web of Science ®Google Scholar
• Santos-Martínez S, Alkhodair A, Nombela-Franco L, et al. Transcatheter aortic valve replacement for residual lesion of the aortic valve following “healed” infective endocarditis. JACC Cardiovasc Interv. 2020;13:1983–1996.
   PubMed Web of Science ®Google Scholar
• Mentias A, Girotra S, Desai MY, et al. Incidence, predictors, and outcomes of endocarditis after transcatheter aortic valve replacement in the United States. JACC Cardiovasc Interv. 2020;13:1973–1982.
   PubMed Web of Science ®Google Scholar
• Allen CJ, Patterson T, Chehab O, et al. Incidence and outcomes of infective endocarditis following transcatheter aortic valve implantation. Expert Rev Cardiovasc Ther. 2020 Oct 18. Epub ahead of print. PMID: 33073603. DOI:10.1080/14779072.2020.1839419.
   PubMed Web of Science ®Google Scholar